Salmeterol Monograph: Long-Acting Beta-2 Agonism, Asthma Combination Therapy and Safety
Evidence-informed pharmacology monograph. Reviewed 10 November 2026. Educational material only; clinical use requires current local product labeling and patient-specific assessment. Clinical overview Salmeterol is a long-acting beta-2 adrenergic receptor agonist (LABA) used for maintenance bronchodilation in selected asthma or COPD regimens. It provides a duration of bronchodilation of approximately 12 hours but has slower onset…